Amphastar Pharmaceuticals Inc
AMPH27.120USD
+0.310+1.16%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.26BMarket Cap
11.50P/E TTM
Amphastar Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
731.97M
13.59%
EPS(YoY)
3.29
15.58%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 731.97M, with a year-on-year change of 13.59%.
What is the Earnings Per Share (EPS) of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 3.294, with a year-on-year change of 15.58%.
What is the net income of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its net income was 159.52M, with a year-on-year change of 15.98%.
What is the net margin of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was 21.79%, with a year-on-year change of 2.10%.
What is the gross margin of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 51.08%, with a year-on-year change of -6.98%.
What is the debt-to-asset ratio of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 38.15%, with a year-on-year change of -2.17%.
What is the Return on Equity (ROE) of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was 23.26%, with a year-on-year change of -1.24%.
What is the Return on Assets (ROA) of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was 10.32%, with a year-on-year change of -15.38%.
What is the operating profit of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its operating profit was 205.42M, with a year-on-year change of 2.87%.
What are the current assets of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its current assets were 534.07M, with a year-on-year change of 9.08%.
What are the total assets of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its total assets of Amphastar Pharmaceuticals Inc were 1.58B, with a year-on-year change of 4.27%.
What are the total liabilities of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Amphastar Pharmaceuticals Inc were 845.17M, with a year-on-year change of -3.24%.
What is the total equity of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its total equity of Amphastar Pharmaceuticals Inc was 732.30M, with a year-on-year change of 14.53%.
What is the net operating income of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Amphastar Pharmaceuticals Inc was 160.09M, with a year-on-year change of 14.74%.
What is the net investment of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its net investment of Amphastar Pharmaceuticals Inc was -124.93M, with a year-on-year change of 80.75%.
What is the net financing of Amphastar Pharmaceuticals Inc?
According to Amphastar Pharmaceuticals Inc's FY2024 earnings report, its net financing of Amphastar Pharmaceuticals Inc was -80.95M, with a year-on-year change of -117.83%.
